Ipamorelin is a selective pentapeptide growth hormone secretagogue that binds to the ghrelin/GHS receptor to stimulate growth hormone release from the pituitary gland. Unlike other GH secretagogues, Ipamorelin is highly selective and does not significantly affect cortisol, prolactin, or ACTH levels at standard research doses.
Preclinical and clinical studies have examined Ipamorelin for its effects on GH pulsatility, bone density, body composition, and recovery markers. Its selectivity profile makes it a valuable research tool for studying GH-axis modulation without the confounding hormonal effects seen with less selective compounds.
Each vial contains 10mg of Ipamorelin in lyophilized form, manufactured to a purity exceeding 98% as confirmed by HPLC analysis. Batch consistency is ensured through rigorous third-party testing and quality assurance protocols.
Store lyophilized at -20C. Reconstituted at 2-8C, use within 60 days.
For research and laboratory use only.
Reviews
There are no reviews yet.